NIH Contributions to WHO COVID-19 Technology Access Pool
Sharing U.S. Government COVID-19 vaccine-related intellectual property and research tools for greater global access. Through the National Institutes of Health (NIH), the United States has recently licensed the intellectual property and research tools for several COVID-19 technologies to the Medicines Patent Pool, through the WHO COVID-19 Technology Access Pool. The licenses include its patent for the stabilized spike protein used in multiple existing COVID-19 vaccines. These licenses will enable manufacturers from around the world to use these technologies.